PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
1-Year Return
73.17%
This Quarter Return
+17.73%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$3.02B
AUM Growth
+$405M
(+15%)
Cap. Flow
+$216M
Cap. Flow
% of AUM
7.15%
Top 10 Holdings %
Top 10 Hldgs %
52.68%
Holding
169
New
33
Increased
34
Reduced
22
Closed
35
Top Buys
| 1 |
BPMC
Blueprint Medicines
BPMC
|
$54M |
| 2 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$39.6M |
| 3 |
Merit Medical Systems
MMSI
|
$33.4M |
| 4 |
ABMD
Abiomed Inc
ABMD
|
$30.6M |
| 5 |
Neurocrine Biosciences
NBIX
|
$27.9M |
Top Sells
| 1 |
Alnylam Pharmaceuticals
ALNY
|
$58.2M |
| 2 |
NXTM
NxStage Medical Inc.
NXTM
|
$34.9M |
| 3 |
AnaptysBio
ANAB
|
$22.8M |
| 4 |
Puma Biotechnology
PBYI
|
$21.7M |
| 5 |
TSRO
TESARO, Inc.
TSRO
|
$21.5M |
Sector Composition
| 1 | Healthcare | 97.13% |
| 2 | Consumer Discretionary | 0.06% |
| 3 | Technology | 0.05% |
| 4 | Industrials | 0% |
